HCWB logo

HCWB HCW Biologics Inc.

NASDAQ Global Market · Biotechnology · Healthcare

$0.75
+0.01 (+1.90%)

HCW Biologics Inc. operates as a preclinical-stage biopharmaceutical firm, primarily engaged in the discovery and advancement of novel immunotherapies. Its research and development efforts are focused on addressing chronic, low-grade inflammation and a spectrum of age-related diseases. The company's leading therapeutic candidates include HCW9218, an injectable immunotherapeutic designed for patien…

Market Cap: $260.4Kwww.hcwbiologics.com

Price

No data yet.

Social Signal Score

50
5d
—
30d
50
4 mentions
—
60d
50
6 mentions
—
90d
49
7 mentions
—
news: 7

Analyst Ratings

3 analysts
Buyconsensus
Strong Buy 0Buy 3Hold 0Sell 0Strong Sell 0

Revenue

$55.5K
$0.00$2.18M$4.36M$6.54M
Mar 2020Sep 2026

Analyst Estimates

FY2025
$-31.38
$-31.38–$-31.38
1 analysts
FY2026
$-4.72
$-4.72–$-4.72
1 analysts
FY2027
$-1.05
$-1.05–$-1.05
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Hing C. Wong
Sector
Healthcare
Industry
Biotechnology
Employees
35
Beta
2.27
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
-7.29
www.hcwbiologics.com